Immediate reduction of white blood cell count after tocilizumab administration was observed in some cases

Mod Rheumatol. 2009;19(3):348-50. doi: 10.1007/s10165-009-0159-z. Epub 2009 Mar 14.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy
  • Cohort Studies
  • Humans
  • Leukopenia / chemically induced*
  • Middle Aged
  • Receptors, Interleukin-6 / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Receptors, Interleukin-6
  • tocilizumab